Larvol Delta - MyMD-Pharmaceuticals-Announces-Issuance-of-US-Patent-for-Use-of-Lead-Candidate-MYMD1-for-Treating-Fibrosis-and-Asthma

isomyosamine (MYMD1) - MyMD Pharma, Akers Biosci

https://www.businesswire.com/news/home/20210824005213/en/MyMD-Pharmaceuticals-Announces-Issuance-of-U.S.-Patent-for-Use-of-Lead-Candidate-MYMD-1-for-Treating-Fibrosis-and-Asthma

Aug 24, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next